Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 8, Pages 2784-2789
Publisher
Proceedings of the National Academy of Sciences
Online
2012-01-24
DOI
10.1073/pnas.1018866109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem cells and survival pathways
- (2011) Dolores Hambardzumyan et al. CELL CYCLE
- Bevacizumab Treatment for Solid Tumors
- (2011) Daniel F. Hayes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- HIF-2 Enhances -Catenin/TCF-Driven Transcription by Interacting with -Catenin
- (2010) H. Choi et al. CANCER RESEARCH
- Endothelial Cell-Initiated Signaling Promotes the Survival and Self-Renewal of Cancer Stem Cells
- (2010) S. Krishnamurthy et al. CANCER RESEARCH
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Activation of -Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
- (2010) L. Liu et al. CLINICAL CANCER RESEARCH
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
- (2010) Olga Méndez et al. Molecular Cancer
- Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
- (2010) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- O2 regulates stem cells through Wnt/β-catenin signalling
- (2010) Jolly Mazumdar et al. NATURE CELL BIOLOGY
- Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
- (2010) Dejuan Kong et al. PLoS One
- Epithelial–Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease
- (2009) Stefania Cannito et al. ANTIOXIDANTS & REDOX SIGNALING
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species
- (2009) Joshua Ö. Haznedar et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Silencing of HIF-1α suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis
- (2009) K Xu et al. CANCER GENE THERAPY
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
- (2009) Hasan Korkaya et al. PLOS BIOLOGY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Notch Signaling Regulates Mammary Stem Cell Function and Luminal Cell-Fate Commitment
- (2008) Toula Bouras et al. Cell Stem Cell
- Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
- (2008) Manfred Johannsen et al. EUROPEAN UROLOGY
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started